Literature DB >> 30244432

Active tuberculosis in patients with systemic lupus erythematosus from Southern China: a retrospective study.

Minxi Lao1,2, Dongying Chen1, Xiangni Wu3, Haihong Chen4, Qian Qiu1, Xiuyan Yang1, Zhongping Zhan5.   

Abstract

To investigate the characteristics and associated factors for Mycobacterium tuberculosis (TB) infection in patients with systemic lupus erythematosus (SLE) from Southern China. A retrospective study of 1108 patients admitted to the First Affiliated Hospital of Sun Yat-Sen University from January 2007 to December 2017 was performed. Demographic and clinical characteristics, laboratory data, and radiographic manifestations were recorded. A total of 59 (5.3%) lupus patients with active TB were included. Pulmonary TB occurred in 41 (69.5%) patients. Single lobe involvement was showed in 14 (34.1%) patients. Multi-lobar involvement, including miliary TB (36.6%), was presented in 27 (65.8%) patients. Lower lobe involvement accounted for 31 (75.6%) of the cases. Extrapulmonary TB occurred in 18 (30.5%) patients. Nearly one-third (35.6%) of the patients developed disseminated TB. T-SPOT.TB assay was performed in 23 patients and positive in 18 patients (78.3%). Nineteen patients (32.2%) had co-infection with TB and other pathogens, most of which were bacterial-associated (52.6%). Lymphopenia was predominant in TB-infected patients, especially in those with disseminated TB. Multivariate logistic regression analysis found that lymphopenia [odds ratio (OR) = 2.19, 95% confidence interval (CI) 1.03-4.63, P = 0.04] and the accumulated doses of glucocorticoid (GC) (OR = 2.32, 95% CI 1.69-3.20, P < 0.001) were associated with TB. TB infection is a common comorbidity in patients with SLE. Manifestations of pulmonary computed tomography (CT) scan are relatively atypical. Co-infection with TB and other pathogens is not rare. Lymphopenia and the accumulated doses of GC are associated with TB infection in lupus patients.

Entities:  

Keywords:  Co-infection; Disseminated tuberculosis; Lymphopenia; Mycobacterium tuberculosis; Systemic lupus erythematosus

Mesh:

Substances:

Year:  2018        PMID: 30244432     DOI: 10.1007/s10067-018-4303-z

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   3.650


  39 in total

1.  Incidence of tuberculosis among patients receiving treatment with oral corticosteroids.

Authors:  P N Agrawal; D Gupta; A N Aggarwal; D Behera
Journal:  J Assoc Physicians India       Date:  2000-09

2.  "The Impact of Mycobacterium tuberculosis Immune Evasion on Protective Immunity: Implications for TB Vaccine Design" - Meeting report.

Authors:  Cesar Boggiano; Katrin Eichelberg; Lakshmi Ramachandra; Jaqueline Shea; Lalita Ramakrishnan; Samuel Behar; Joel D Ernst; Steven A Porcelli; Markus Maeurer; Hardy Kornfeld
Journal:  Vaccine       Date:  2017-05-02       Impact factor: 3.641

Review 3.  HIV and tuberculosis: a deadly human syndemic.

Authors:  Candice K Kwan; Joel D Ernst
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

4.  SLICC/ACR damage index independently associated with left ventricular diastolic dysfunction in patients with systemic lupus erythematosus.

Authors:  Q Shang; G W K Yip; L S Tam; Q Zhang; J E Sanderson; Y Y Lam; C M Li; T Wang; E K M Li; C M Yu
Journal:  Lupus       Date:  2012-05-03       Impact factor: 2.911

5.  Tuberculosis in solid organ transplant recipients at a tertiary hospital in the last 20 years in Barcelona, Spain.

Authors:  J F García-Goez; L Linares; N Benito; C Cervera; F Cofán; M J Ricart; M Navasa; F Pérez-Villa; J González; A Moreno
Journal:  Transplant Proc       Date:  2009 Jul-Aug       Impact factor: 1.066

Review 6.  The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus.

Authors:  D Gladman; E Ginzler; C Goldsmith; P Fortin; M Liang; M Urowitz; P Bacon; S Bombardieri; J Hanly; E Hay; D Isenberg; J Jones; K Kalunian; P Maddison; O Nived; M Petri; M Richter; J Sanchez-Guerrero; M Snaith; G Sturfelt; D Symmons; A Zoma
Journal:  Arthritis Rheum       Date:  1996-03

7.  CD4 lymphocyte dynamics in Tanzanian pulmonary tuberculosis patients with and without HIV co-infection.

Authors:  Aase B Andersen; Nyagosya S Range; John Changalucha; George Praygod; Jeremiah Kidola; Daniel Faurholt-Jepsen; Henrik Krarup; Harleen M S Grewal; Henrik Friis
Journal:  BMC Infect Dis       Date:  2012-03-21       Impact factor: 3.090

8.  CD4+ T-lymphopenia in HIV negative tuberculous patients at King Khalid University Hospital in Riyadh, Saudi Arabia.

Authors:  Abdulkarim Al-Aska; A R Al-Anazi; S S Al-Subaei; M A Al-Hedaithy; M A Barry; A M Somily; F Buba; U Yusuf; N A Al Anazi
Journal:  Eur J Med Res       Date:  2011-06-21       Impact factor: 2.175

9.  CD4 cell levels during treatment for tuberculosis (TB) in Ethiopian adults and clinical markers associated with CD4 lymphocytopenia.

Authors:  Sten Skogmar; Thomas Schön; Taye Tolera Balcha; Zelalem Habtamu Jemal; Gudeta Tibesso; Jonas Björk; Per Björkman
Journal:  PLoS One       Date:  2013-12-16       Impact factor: 3.240

10.  A Rare Case of Disseminated Tuberculosis of the Bone Marrow in Systemic Lupus Erythematosus: Case Report.

Authors:  Dongying Chen; Zheng Yang; Ying Yang; Zhongping Zhan; Xiuyan Yang
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

View more
  5 in total

1.  Factors associated with active tuberculosis in Colombian patients with systemic lupus erythematosus: a case-control study.

Authors:  Luis Alonso González-Naranjo; Jaime Alberto Coral-Enríquez; Mauricio Restrepo-Escobar; Carlos Horacio Muñoz-Vahos; Daniel Jaramillo-Arroyave; Adriana Lucía Vanegas-García; Ruth Eraso; Gloria Vásquez; Fabián Jaimes
Journal:  Clin Rheumatol       Date:  2020-06-11       Impact factor: 2.980

2.  Prevalence and risk factors of active tuberculosis in patients with rheumatic diseases: a multi-center, cross-sectional study in China.

Authors:  Xiaoqing Liu; Lifan Zhang; Fengchun Zhang; Xiaofeng Zeng; Yan Zhao; Qian Wang; Shengyun Liu; Xiaoxia Zuo; Zhiyi Zhang; Huaxiang Wu; Sheng Chen; Hongbin Li; Ping Zhu; Lijun Wu; Wencheng Qi; Yi Liu; Miaojia Zhang; Huaxiang Liu; Dong Xu; Wenjie Zheng; Yueqiu Zhang; Xiaochun Shi; Lishuai Han; Yaou Zhou; Yanping Zhao; Wenwen Wang; Ting Li; Ning Tie; Kui Zhang; Cainan Luo; Baoqi Gong; Yi Zhao; Chengyin Lv; Lijun Song; Qingjun Wu; Yunyun Fei; Lei Zhang; Hui Luo; Jiaying Sun; Jing Xue; Liyang Gu; Jing Wang; Qing Han; Kuerbanjiang Yimaity; Jiaxin Zhou; Lidan Zhao; Sainan Bian; Wufang Qi; Yanhong Li; Yujing Zhu; Huijun Han; Susu Liao; Gaifen Liu
Journal:  Emerg Microbes Infect       Date:  2021-12       Impact factor: 7.163

3.  Tuberculosis in Children with Rheumatic Diseases Treated with Biologic Disease-Modifying Anti-Rheumatic Drugs.

Authors:  Chengappa Kavadichanda; M B Adarsh; Sajal Ajmani; Ilaria Maccora; S Balan; A V Ramanan; Vikas Agarwal; Latika Gupta
Journal:  Mediterr J Rheumatol       Date:  2021-12-27

4.  Correlation between peripheral blood lymphocyte subpopulations and primary systemic lupus erythematosus.

Authors:  Yan Feng; Zhijun Li; Changhao Xie; Fanglin Lu
Journal:  Open Life Sci       Date:  2022-08-10       Impact factor: 1.311

5.  Incidence and prevalence of tuberculosis in systemic lupus erythematosus patients: A systematic review and meta-analysis.

Authors:  Qian Wu; Yang Liu; Wei Wang; Yu Zhang; Kui Liu; Song-Hua Chen; Bin Chen
Journal:  Front Immunol       Date:  2022-07-22       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.